A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Enrollment of subjects with mild to moderate facial acne. Efficacy was assessed by using an Investigator\'s Global Assessment scale (IGA 5 point scale) and by counting the number of inflammatory and non-inflammatory lesions on the face at Baseline and Weeks 4, 8, and 12. Safety assessments included the investigator\'s assessment of local cutaneous tolerance of the treated skin (dryness, non-lesional erythema, peeling, stinging, burning, and itching, vital signs, and adverse events (AEs).
Epistemonikos ID: bcc7f4d5bcf3498f7bad9e4e4265dd894f217a22
First added on: May 21, 2024